Loading clinical trials...
Loading clinical trials...
Spinocerebellar Ataxia (SCA) refers to a family of genetic diseases that cause progressive problems with gait and balance, as well as other debilitating symptoms. This is a randomized controlled pilot...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborators
NCT06672445 · Spinocerebellar Ataxia Type 2
NCT07185347 · Spinocerebellar Ataxia 27B (SCA27B)
NCT05822908 · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, and more
NCT06633003 · Spinocerebellar Ataxia
NCT02440763 · Spinocerebellar Ataxia
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions